Cleared Traditional

K843183 - STRATUS CORTISOL FLUOROMETRIC ENZYME

K843183 is the FDA 510(k) clearance for STRATUS CORTISOL FLUOROMETRIC ENZYME by American Dade. It is a Class 2 Chemistry device (product code CGR) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
35d
Days
Class 2
Risk

K843183 is an FDA 510(k) clearance for the STRATUS CORTISOL FLUOROMETRIC ENZYME. Classified as Radioimmunoassay, Cortisol (product code CGR), Class II - Special Controls.

Submitted by American Dade (Mchenry, US). The FDA issued a Cleared decision on September 17, 1984 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1205 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Dade devices

Submission Details

510(k) Number K843183 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 1984
Decision Date September 17, 1984
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 88d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGR Radioimmunoassay, Cortisol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1205
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGR Radioimmunoassay, Cortisol

All 45
Devices cleared under the same product code (CGR) and FDA review panel - the closest regulatory comparables to K843183.
ACTIVE CORTISOL DSL 2000-SP
K850141 · Diagnostic Systems Laboratories, Inc. · Feb 1985
SOPHEIA/MP CORTISOL EIA KIT
K850008 · Diagnostic Products Corp. · Feb 1985
LEECO CORTISOL-QUANT
K843384 · Leeco Diagnostics, Inc. · Sep 1984
CORNING MAGIC CORTISOL RADIOIMMUNO
K841641 · Corning Medical & Scientific · Sep 1984
CORTI-COTE CORTISOL SOLID PHASE RADIO
K842365 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1984
EMIT SRD MANUAL CORTISOL ASSAY
K831141 · Syva Co. · May 1983